Why write ten lines of code when one will do? From magic variable swaps to high-speed data counting, these Python snippets ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Learn how Zero-Knowledge Proofs (ZKP) provide verifiable tool execution for Model Context Protocol (MCP) in a post-quantum world. Secure your AI infrastructure today.

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. We’re not going to string you along here.

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...